During his surgical residency at
Virginia Mason Medical Center in the early 1980s, Moll says he was “struck by the size of the incision and injury created just to get inside the body.” He also obtained an M.S. degree in business management from
Stanford University. Following its acquisition by Eli Lilly, Origin MedSystem became an operating company within
Guidant in 1992. Moll served as medical director of Guidant's surgical division until 1995. Moll left Intuitive Surgical in 2002 to become founder & CEO of
Hansen Medical, which developed robotic systems for
vascular and interventional
electrophysiology procedures, and a robotically steered
catheter sheath. Hansen Medical received Frost & Sullivan's Product Innovation Award in 2008 for US Image-Guided and Robotic Assisted Surgery Devices. Moll was a board member of Mako Surgical until its sale in 2013. Auris Health's Monarch system is a diagnostic tool that uses robotic-assisted
endoscopy. Its application in the earlier and more accurate diagnosis of
lung cancer was approved by the
FDA in 2018.
Johnson & Johnson (J&J) announced its acquisition of Auris Health in February 2019; In 2016, Moll joined the board of RefleXion, a medical equipment company developing a biologically guided
radiation therapy system for cancer treatment. == References ==